Infarction Cerebral Completed Phase 4 Trials for Acetylsalicylic acid (DB00945)

Also known as: Cerebral Infarct / Cerebral Infarction / Cerebral Infarctions / Cerebral infarction, unspecified / Cerebral infarction (disorder) / Infarct cerebral / Occlusion of cerebral arteries / Occlusion of cerebral artery (disorder) / Cerebral artery occlusion, unspecified / Cerebral artery occlusion

IndicationStatusPhase
DBCOND0158720 (Infarction Cerebral)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00766896Platelet Hyperreactivity to Aspirin and StrokeDiagnostic
NCT00741286Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial DopplerTreatment
NCT00272454Cilostazol in Acute Ischemic Stroke Treatment (CAIST)Treatment
NCT00234065Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)Prevention
NCT00004727Antiplatelet Therapy to Prevent Stroke in African AmericansPrevention